SPONSOR
Peking Union Medical College Hospital
Total Trials
22
Recruiting
22
Phases
Phase 2
Conditions studied: Adolescent Idiopathic ScoliosisDermatomyositisIntestinal IschemiaCritical IllnessEnteral Nutrition FeedingHemodynamicsUltrasonography, DopplerCervical Cancer Stage IB2Extranodal NK/T-cell LymphomaCervical Cancer
Peking Union Medical College Hospital is a clinical research sponsor with 22 registered studies on ClinicalTrials.gov, of which 22 are actively recruiting participants. Research covers conditions including Adolescent Idiopathic Scoliosis, Dermatomyositis, Intestinal Ischemia, Critical Illness.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peking Union Medical College Hospital
How many clinical trials has Peking Union Medical College Hospital sponsored?
ClinicalMetric currently tracks 22 clinical trials sponsored by Peking Union Medical College Hospital, of which 22 are actively recruiting participants. These trials cover conditions including Adolescent Idiopathic Scoliosis, Dermatomyositis, Intestinal Ischemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peking Union Medical College Hospital research focus on?
Peking Union Medical College Hospital clinical trials span Adolescent Idiopathic Scoliosis, Dermatomyositis, Intestinal Ischemia, Critical Illness, Enteral Nutrition Feeding, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Peking Union Medical College Hospital clinical trial?
To participate in a Peking Union Medical College Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking Union Medical College Hospital trials with current recruitment status updated daily.
Clinical Trials by Peking Union Medical College Hospital
NCT06279468
Recruiting
Clinical Effectiveness of Intervertebral Disc Release in Treating Lenke 5 Adolescent Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis
NCT07377058
Recruiting
RCT of Tocilizumab for Anti-MDA5+DM
Dermatomyositis
NCT07001943
Recruiting
Correlation Study Between SMA Blood Flow Reactivity and Acute Gastrointestinal Injury in Critically Ill Patients
Intestinal Ischemia
NCT06836869
Recruiting
Modified Tumor-free Techniques Operation to Cervical Cancer
Cervical Cancer Stage IB2
NCT06824883 Phase 2
Recruiting
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
Extranodal NK/T-cell Lymphoma
NCT06562166 Phase 2
Recruiting
Online Adaptive Radiotherapy for Cervical Cancer
Cervical Cancer
NCT06063018 Phase 2
Recruiting
RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer
Cervical Cancer Recurrent
NCT06499974
Recruiting
POASAC Study (Preoperative Anemia Severity and Classification Study)
Anemia
NCT05015348
Recruiting
Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients with Hyperlipidemia
Hyperlipidemias
NCT05517291
Recruiting
DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease
Safety Issues
NCT06773832
Recruiting
AI in Predicting Polyp Pathology and Endoscopic Classification
Colorectal Polyps
NCT07101237
Recruiting
An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.
Hepatocellular Carcinoma (HCC)
NCT05023564
Recruiting
PUMCH Dementia Longitudinal Cohort Study
Dementia
NCT06035016
Recruiting
Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer
HER2-positive Breast Cancer
NCT06660628
Recruiting
Large Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast Cancer
Breast Cancer
NCT06295926 Phase 2
Recruiting
Serplulimab Combined With CCRT for LS-SCLC.
Small Cell Lung Cancer
NCT06194708
Recruiting
Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer （NORESTO Study）
Rectal Cancer
NCT07679399 Phase 2
Recruiting
A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer.
Biliary Tract Neoplasms Immunotherapy
NCT06168032
Recruiting
COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
COVID-19 Recurrent
NCT06802042
Recruiting
Effect of Lactobacillus DSM17938+ on Functional Constipation and Intestinal Flora in Pregnant Women
Functional Constipation (FC)
NCT06545721
Recruiting
Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome
Polycystic Ovary Syndrome
NCT07324733
Recruiting
Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Imaging
Primary Sjögren Syndrome
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology